[1]李文龙 张海龙 李阳阳 王会超 刘又文△.活血通络膏联合低剂量利伐沙班预防全髋关节置换术后深静脉血栓形成的临床研究[J].中国中医骨伤科杂志,2017,25(02):32-35.
　LI Wenlong ZHANG Hailong LI Yangyang WANG Huichao LIU Youwen.Clinical Study of Application of Huoxuetongluo Ointment Combing Low Dose of Rivaroxaban in Preventing Deep Venous Thrombosis after Total Hip Arthroplasty[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2017,25(02):32-35.
点击复制

活血通络膏联合低剂量利伐沙班预防全髋关节置换术后深静脉血栓形成的临床研究()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第25卷
期数:
2017年02期
页码:
32-35
栏目:
临床研究
出版日期:
2017-02-15

文章信息/Info

Title:
Clinical Study of Application of Huoxuetongluo Ointment Combing Low Dose of Rivaroxaban in Preventing Deep Venous Thrombosis after Total Hip Arthroplasty
文章编号:
1005-0205(2017)02-0032-04
作者:
李文龙1 张海龙1 李阳阳1 王会超2 刘又文2△
1河南中医药大学(郑州,450008) 2河南省洛阳正骨医院,河南省骨科医院 △通信作者 E-mail:liuyouwen543@sina.com
Author(s):
LI Wenlong1 ZHANG Hailong1 LI Yangyang1 WANG Huichao2 LIU Youwen2△
1Henan University of Traditional Chinese Medicine,Zhengzhou 450008,China; 2Luoyang Orthopedic-Traumatological Hospital,Luoyang 471002,Henan China.
关键词:
活血通络膏;  利伐沙班;  髋关节置换;  深静脉血栓;  临床研究
Keywords:
Huoxuetongluo ointment;  rivaroxaban;  total hip arthroplasty;  deep venous thrombosis;  clinical research
分类号:
R687.4
文献标志码:
A
摘要:
目的:探讨活血通络膏联合低剂量利伐沙班预防全髋关节置换术(THA)术后并发下肢深静脉血栓形成(DVT)的有效性及安全性。方法:将72例接受单侧THA手术的患者随机分为试验组、对照组,每组各36例。试验组予低剂量利伐沙班片口服,联合活血通络膏外敷,对照组予正常剂量利伐沙班片口服,连续2周。观察两组患者凝血指标、大腿及小腿周径差值、DVT形成情况及用药安全情况。结果:1)试验组和对照组术后APTT,PT均明显延长(P<0.05),D-D、患肢大腿及小腿周径差值均明显降低(P<0.05); 2)两组间比较,差异均无统计学意义(P>0.05); 3)两组患者HGB、术中出血量、输血量及术后引流量比较,差异均无统计学意义(P>0.05); 4)试验组下肢深静脉血栓发生率为8.3%(3/36),对照组为2.8%(1/36),差异无统计学意义(P>0.05); 5)两组患者治疗期间均无消化道出血、皮肤黏膜出血、胃肠系统异常等不良反应发生,肝、肾功能检查均未见明显异常。结论:应用活血通络膏联合低剂量利伐沙班预防THA术后DVT,能减少利伐沙班用量、降低DVT发生率,有效性和安全性与正常剂量利伐沙班相当。
Abstract:
Objective: To observe the effectiveness and safety of application of Huoxuetongluo ointment combing low dose of Rivaroxaban in preventing deep venous thrombosis(DVT)after total hip arthroplasty(THA). Methods: 72 patients underwent unilateral THA were randomly divided into 2 groups, 36 cases in each group. The patients in the treatment group were treated with external application of Huoxuetongluo ointment combing oral application of low dose of Rivaroxaban, while the others in control group were treated with normal dose of Rivaroxaban orally. Results: In both groups, PT and APTT were significantly prolonged(P<0.05), and D-D, leg thigh and calf circumference difference were significantly reduced(P<0.05). There was no significant difference between the 2 groups(P>0.05).There was no statistical difference in HGB, intraoperative blood loss, total transfusions and postoperative drainage between the two groups(P>0.05). The incidence rate of lower deep vein thrombosis in treatment group was 8.3%(3/36)and control group 2.8%(1/36), and the difference was not statistically significant(P>0.05).No adverse effect was observed in both groups such as alimentary tract hemorrhage, skin and mucosa hemorrhage, alimentary tract indisposition, hepatic disfunction and renal disfunction. Conclusion: Application of Huoxuetongluo ointment combing low dose of Rivaroxaban in preventing DVT after THA can reduce the dosage of Rivaroxaban and reduce the incidence of DVT. The effectiveness and safety are comparable to the normal dose of Shaaban.

参考文献/References:

[1] 李文龙,范亚楠,张蕾蕾,等.微创全髋关节置换术直接前侧入路与外侧小切口入路的对比研究[J].中医正骨,2016,28(3):24-29.
[2] 周煜虎,武政,宋建华,等.血栓通注射液联合利伐沙班治疗髋关节置换术后下肢深静脉血栓的疗效观察[J].现代药物与临床,2015,30(12):1490-1493.
[3] Geerts WH,Pineo GF,Heit JA,et al.Prevention of venous thromboembolism:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126(3):338S-400S.
[4] 张建方,金国强,姚航军,等.补阳还五汤加减预防髋关节置换术后深静脉血栓形成的临床研究[J].中医正骨,2013,25(2):19-21.
[5] Quinlan DJ,Eikelboom JW,Dahl OE,et al.Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery[J].J Thromb Haemost,2007,5(7):1438-1443.
[6] Weber M,Burmeister H,Flueckiger G,et al.The use of weightbearing radiographs to assess the stability of supination-external rotation fractures of the ankle[J].Arch Orthop Trauma Surg,2010,130(5):693-698.
[7] 王利,袁宏,哈巴西·卡肯,等.利伐沙班在人工关节置换术后深静脉血栓预防中的应用研究[J].新疆医科大学学报,2015,38(8):991-995.
[8] Agnelli G,Becattini C.Acute pulmonary embolism[J].N Engl J Med,2010,363(3):266-274.
[9] Baglin T.Clinical use of new oral anticoagulant drugs:dabigatran and rivaroxaban[J].Br J Haematol,2013,163(2):160-167.
[10] Yen SH,Lin PC,Kuo FC,et al.Thromboprophylaxis after minimally invasive total knee arthroplasty:a comparison of rivaroxaban and enoxaparin[J].Biomed J,2014,37(4):199-204.
[11] Alves C,Batel-Marques F,Macedo AF.Apixaban and rivaroxaban safety after hip and knee arthroplasty:a meta-analysis[J].J Cardiovasc Pharmacol Ther,2012,17(3):266-276.
[12] 肖瑜,张福江,任凯晶,等.利伐沙班预防髋或膝关节置换术后静脉血栓栓塞症的Meta 分析[J].天津医药,2012,40(5):502-506.
[13] 杨礼庆.口服利伐沙班预防人工全髋关节置换术后深静脉血栓的临床研究[J].中国临床药理学杂志,2013,29(4):260-263.
[14] 展宝明,陈达,张庆文.桃红四物汤预防全髋关节置换术后下肢深静脉血栓形成的临床研究[J].中医正骨,2014,26(9):25-28.
[15] Chahal GS,Saithna A,Brewster M,et al.A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis[J].Ortop Traumatol Rehabil,2013,15(2):125-129.
[16] 赵振军,郭玉芬.D-二聚体水平与骨折后下肢静脉血栓的相关性研究[J].医药前沿,2013,9(25):188-189.

备注/Memo

备注/Memo:
基金项目:2015年度河南省中医药科学研究专项课题 (2015ZY02069)
更新日期/Last Update: 2017-09-08